Prolonged treatment for acute symptomatic refractory status epilepticus: outcome in children.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12913208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
High-dose suppressive therapy (HDST) is used to treat refractory status epilepticus (RSE). Prolonged therapy is required in some cases, and prognosis is important in making therapeutic decisions. The authors therefore studied the long-term outcome in previously normal children who survived prolonged HDST for acute symptomatic RSE. All have intractable epilepsy, and none returned to baseline.
Medical subject headings
- Anticonvulsants
- Status Epilepticus